Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity

By Kaku Kohei   Daida Hiroyuki   Kashiwagi Atsunori   Yamashina Akira   Yamazaki Tsutomu   Momomura Shin-ichi   Iwase Takashi   Yamasaki Yoshimitsu   Nagatsuka Kazuyuki   Kitagawa Kazuo   Kawamori Ryuzo  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2925-2932

Informa Healthcare

Access to resources Recommend Favorite

N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes

By Grauslund Jakob   Nybo Mads   Green Anders   Sjølie Anne K.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 6, 2010-10 ,pp. : 392-398

Informa Healthcare

Access to resources Recommend Favorite

Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes

By Home Philip  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 989-998

Informa Healthcare

Access to resources Recommend Favorite

Risk factors for microvascular and macrovascular complications in men and women with type 2 diabetes

By Wändell Per Erik  

Scandinavian Journal of Primary Health Care, Vol. 17, Iss. 2, 1999-06 ,pp. : 116-121

Informa Healthcare

Access to resources Recommend Favorite

Ketoacidosis at onset of type 1 diabetes is a predictor of long‐term glycemic control

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 19, Iss. 2, 2018-03 ,pp. : 320-328

John Wiley & Sons Inc

Access to resources Recommend Favorite